Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid plus chemotherapy as initial treatment for unresectable metastatic colorectal cancer
jRCTs031180417Completed
- Start
- Apr 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of tranexamic acid in metastatic colorectal adenocarcinoma (mCRC). Primary endpoint: Progression-free survival. Started Apr 2019; status: completed.
02
Drugs
tranexamic acid
03
Conditions
metastatic colorectal adenocarcinoma (mCRC)
Beyond the preview
Go deeper on jRCTs031180417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180417.